Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06890455

Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections

Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation This study aims to detect the relationship between fecal calprotectin and Blastocystis hominis and Entamoeba histolytica infections.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Fecal Calprotectin in Intestinal Protozoa

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

120 fecal samples will be collected as the following:

  • 40 samples from patients complaining of gastrointestinal manifestations and only infected with B.hominis and E.histolytica.
  • 40 samples from patients complaining of gastrointestinal manifestations without any protozoal infection.
  • 40 healthy control cross-matched volunteers (without gastrointestinal manifestations, or intestinal parasites).

Exclusion criteria

  • persons received antiparasitic drugs or antibiotic 2 weeks before sample collection Patients with mixed intestinal protozoa Patients with intestinal protozoa rather than Entamoeba histolytica and Blastocystis

Treatment and study plan

Primary outcomes

  1. Prevalence of Blastocystis and Entamoeba

    Time frame: 2 months

Secondary outcomes

  1. Number of persons have high fecal calprotectin

    Time frame: 6 months

Study contacts

Contact information is provided by the study sponsor or research team.

Youstina Kamel Boles, Demonstrator

CONTACT

[email protected]

+20 12 73435308

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Mar 24, 2025
Registry last updated
Mar 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.